{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:10:01Z","timestamp":1792919401602,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03105-9","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T19:35:52Z","timestamp":1655408152000},"page":"500-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A systematic review of molecular alterations in invasive non-functioning pituitary adenoma"],"prefix":"10.1007","volume":"77","author":[{"given":"Nazanin","family":"Hosseinkhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Honardoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cheraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Hashemi-Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4313-8440","authenticated-orcid":false,"given":"Mohammad E.","family":"Khamseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"issue":"4","key":"3105_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11102-012-0454-0","volume":"16","author":"M Gruppetta","year":"2013","unstructured":"M. Gruppetta, C. Mercieca, J. Vassallo, Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary 16(4), 545\u2013553 (2013)","journal-title":"Pituitary"},{"issue":"2","key":"3105_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11102-018-0869-3","volume":"21","author":"G Ntali","year":"2018","unstructured":"G. Ntali, J.A. Wass, Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 21(2), 111\u2013118 (2018)","journal-title":"Pituitary"},{"issue":"4","key":"3105_CR3","doi-asserted-by":"publisher","first-page":"bvaa021","DOI":"10.1210\/jendso\/bvaa021","volume":"4","author":"PU Freda","year":"2020","unstructured":"P.U. Freda, J.N. Bruce, A.G. Khandji, Z. Jin, R.A. Hickman, E. Frey et al. Presenting features in 269 patients with clinically nonfunctioning pituitary adenomas enrolled in a prospective study. J. Endocr. Soc. 4(4), bvaa021 (2020)","journal-title":"J. Endocr. Soc."},{"issue":"2","key":"3105_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11102-017-0855-1","volume":"21","author":"E Manojlovic-Gacic","year":"2018","unstructured":"E. Manojlovic-Gacic, B.E. Engstr\u00f6m, O. Casar-Borota, Histopathological classification of non-functioning pituitary neuroendocrine tumors. Pituitary 21(2), 119\u2013129 (2018)","journal-title":"Pituitary"},{"issue":"4","key":"3105_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","volume":"122","author":"AS Micko","year":"2015","unstructured":"A.S. Micko, A. W\u00f6hrer, S. Wolfsberger, E. Knosp, Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J. Neurosurg. 122(4), 803\u2013811 (2015)","journal-title":"J. Neurosurg."},{"issue":"10","key":"3105_CR6","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1210\/js.2019-00163","volume":"3","author":"J Maletkovic","year":"2019","unstructured":"J. Maletkovic, A. Dabbagh, D. Zhang, A. Zahid, M. Bergsneider, M.B. Wang et al. Residual Tumor Confers a 10-Fold Increased Risk of Regrowth in Clinically Nonfunctioning Pituitary Tumors. J. Endocr. Soc. 3(10), 1931\u20131941 (2019)","journal-title":"J. Endocr. Soc."},{"issue":"10","key":"3105_CR7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s12094-018-1868-6","volume":"20","author":"PD Delgado-L\u00f3pez","year":"2018","unstructured":"P.D. Delgado-L\u00f3pez, J. Pi-Barrio, M.T. Due\u00f1as-Polo, M. Pascual-Llorente, M.C. Gord\u00f3n-Bola\u00f1os, Recurrent non-functioning pituitary adenomas: a review on the new pathological classification, management guidelines and treatment options. Clin. Transl. Oncol. 20(10), 1233\u20131245 (2018)","journal-title":"Clin. Transl. Oncol."},{"issue":"5","key":"3105_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1055\/s-0030-1253579","volume":"20","author":"MT Walsh","year":"2010","unstructured":"M.T. Walsh, W.T. Couldwell, Symptomatic cystic degeneration of a clinically silent corticotroph tumor of the pituitary gland. Skull Base 20(5), 367\u2013370 (2010)","journal-title":"Skull Base"},{"issue":"1","key":"3105_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"J. Trouillas, P. Roy, N. Sturm, E. Dantony, C. Cortet-Rudelli, G. Viennet et al. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathologica 126(1), 123\u2013135 (2013)","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"3105_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-18-0749","volume":"180","author":"S Asioli","year":"2019","unstructured":"S. Asioli, A. Righi, M. Iommi, C. Baldovini, F. Ambrosi, F. Guaraldi et al. Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre. Eur. J. Endocrinol. 180(2), 127\u201334. (2019)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"3105_CR11","doi-asserted-by":"publisher","first-page":"R69","DOI":"10.1530\/JME-12-0113","volume":"49","author":"O Mete","year":"2012","unstructured":"O. Mete, S. Ezzat, S.L. Asa, Biomarkers of aggressive pituitary adenomas. J. Mol. Endocrinol. 49(2), R69\u2013R78 (2012)","journal-title":"J. Mol. Endocrinol."},{"key":"3105_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fendo.2019.00007","volume":"10","author":"Q Yang","year":"2019","unstructured":"Q. Yang, X. Li, Molecular Network Basis of Invasive Pituitary Adenoma: A Review. Front Endocrinol. 10, 7 (2019)","journal-title":"Front Endocrinol."},{"key":"3105_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.wneu.2017.01.010","volume":"100","author":"Y Chen","year":"2017","unstructured":"Y. Chen, H.-L. Chuan, S.-Y. Yu, C.-Z. Li, Z.-B. Wu, G.-L. Li et al. A novel invasive-related biomarker in three subtypes of nonfunctioning pituitary adenomas. World Neurosurg. 100, 514\u201321. (2017)","journal-title":"World Neurosurg."},{"issue":"13","key":"3105_CR14","first-page":"2703","volume":"57","author":"WE Farrell","year":"1997","unstructured":"W.E. Farrell, D.J. Simpson, J.E. Bicknell, A.J. Talbot, A.S. Bates, R.N. Clayton, Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. Cancer Res. 57(13), 2703\u20132709 (1997)","journal-title":"Cancer Res."},{"issue":"3","key":"3105_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF02738884","volume":"10","author":"RV Lloyd","year":"1999","unstructured":"R.V. Lloyd, B.W. Scheithauer, T. Kuroki, S. Vidal, K. Kovacs, L. Stefaneanu, Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr. Pathol. 10(3), 229\u201335. (1999)","journal-title":"Endocr. Pathol."},{"issue":"2","key":"3105_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1365-2265.2003.01598.x","volume":"58","author":"C McCabe","year":"2003","unstructured":"C. McCabe, J. Khaira, K. Boelaert, A. Heaney, L. Tannahill, S. Hussain et al. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor\u20102 (FGF\u20102) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin. Endocrinol. 58(2), 141\u2013150 (2003)","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"3105_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s13167-010-0028-z","volume":"1","author":"X Zhan","year":"2010","unstructured":"X. Zhan, D.M. Desiderio, The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas. EPMA J. 1(3), 439\u2013459 (2010)","journal-title":"EPMA J."},{"issue":"4","key":"3105_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.gpb.2012.08.004","volume":"10","author":"L Hood","year":"2012","unstructured":"L. Hood, Q. Tian, Systems approaches to biology and disease enable translational systems medicine. Genomics, Proteom. Bioinforma. 10(4), 181\u2013185 (2012)","journal-title":"Genomics, Proteom. Bioinforma."},{"issue":"10","key":"3105_CR19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1056\/NEJMe1200656","volume":"366","author":"DL Longo","year":"2012","unstructured":"D.L. Longo, Tumor heterogeneity and personalized medicine. N. Engl. J. Med. 366(10), 956\u2013957 (2012)","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"3105_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","volume":"168","author":"JE Bradner","year":"2017","unstructured":"J.E. Bradner, D. Hnisz, R.A. Young, Transcriptional addiction in cancer. Cell 168(4), 629\u201343. (2017)","journal-title":"Cell"},{"key":"3105_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"J. O\u2019Brien, H. Hayder, Y. Zayed, C. Peng, Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. 9, 402 (2018)","journal-title":"Front. Endocrinol."},{"issue":"1","key":"3105_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Y. Peng, C.M. Croce, The role of MicroRNAs in human cancer. Signal Transduct. Target. Ther. 1(1), 1\u20139 (2016)","journal-title":"Signal Transduct. Target. Ther."},{"issue":"W1","key":"3105_CR23","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"M.V. Kuleshov, M.R. Jones, A.D. Rouillard, N.F. Fernandez, Q. Duan, Z. Wang et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44(W1), W90\u2013W7. (2016)","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"3105_CR24","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"D. Szklarczyk, A.L. Gable, D. Lyon, A. Junge, S. Wyder, J. Huerta-Cepas et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47(D1), D607\u2013D13. (2019)","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"3105_CR25","first-page":"1","volume":"5","author":"H Han","year":"2015","unstructured":"H. Han, H. Shim, D. Shin, J.E. Shim, Y. Ko, J. Shin et al. TRRUST: a reference database of human transcriptional regulatory interactions. Sci. Rep. 5(1), 1\u201311 (2015)","journal-title":"Sci. Rep."},{"issue":"D1","key":"3105_CR26","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Y. Chen, X. Wang, miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 48(D1), D127\u2013D131 (2020)","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"3105_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/jcm8050695","volume":"8","author":"M Sato","year":"2019","unstructured":"M. Sato, R. Tamura, H. Tamura, T. Mase, K. Kosugi, Y. Morimoto et al. Analysis of tumor angiogenesis and immune microenvironment in non-functional pituitary endocrine tumors. J. Clin. Med. 8(5), 695 (2019)","journal-title":"J. Clin. Med."},{"issue":"8","key":"3105_CR28","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.3390\/ijms21082831","volume":"21","author":"S Uraki","year":"2020","unstructured":"S. Uraki, H. Ariyasu, K. Takeshima, S. Morita, H. Inaba, H. Furuta et al. MSH6\/2 and PD-L1 expressions are associated with tumor growth and invasiveness in silent pituitary adenoma subtypes. Int. J. Mol. Sci. 21(8), 2831 (2020)","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"3105_CR29","first-page":"2635","volume":"35","author":"W Jia","year":"2015","unstructured":"W. Jia, J. Zhu, T.A. Martin, A. Jiang, A.J. Sanders, W.G. Jiang, Epithelial-mesenchymal transition (EMT) markers in human pituitary adenomas indicate a clinical course. Anticancer Res. 35(5), 2635\u20132643 (2015)","journal-title":"Anticancer Res."},{"issue":"3","key":"3105_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3803\/EnM.2019.34.3.314","volume":"34","author":"YH Kim","year":"2019","unstructured":"Y.H. Kim, J.H. Kim, Transcriptome analysis identifies an attenuated local immune response in invasive nonfunctioning pituitary adenomas. Endocrinol. Metab. 34(3), 314\u2013322 (2019)","journal-title":"Endocrinol. Metab."},{"key":"3105_CR31","doi-asserted-by":"crossref","unstructured":"P. Matou\u0161ek, P. Buzrla, \u0160. Reguli, J. Kraj\u010da, J. Dvo\u0159\u00e1\u010dkov\u00e1, R. Lipina, Factors that predict the growth of residual nonfunctional pituitary adenomas: correlations between relapse and cell cycle markers. BioMed Res. Int. 2018, 1\u20139 (2018)","DOI":"10.1155\/2018\/1876290"},{"issue":"02","key":"3105_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-2007-991131","volume":"116","author":"W Saeger","year":"2008","unstructured":"W. Saeger, B. L\u00fcdecke, D. L\u00fcdecke, Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas. Exp. Clin. Endocrinol. Diabetes 116(02), 80\u201385 (2008)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"3105_CR33","doi-asserted-by":"crossref","unstructured":"X. Wang, Y. Fang, Y. Zhou, X. Guo, K. Xu, C. Li, et al. SDF-1\u03b1\/MicroRNA-134 axis regulates nonfunctioning pituitary neuroendocrine tumor growth via targeting VEGFA. Front. Endocrinol. 952, 1\u201310 (2020)","DOI":"10.3389\/fendo.2020.566761"},{"key":"3105_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.anndiagpath.2019.04.016","volume":"41","author":"G Trott","year":"2019","unstructured":"G. Trott, B.R. Ongaratti, C.B. de Oliveira Silva, G.D. Abech, T. Haag, C.G.S.L. Rech et al. PTTG overexpression in non-functioning pituitary adenomas: Correlation with invasiveness, female gender and younger age. Ann. Diagnostic Pathol. 41, 83\u201389 (2019)","journal-title":"Ann. Diagnostic Pathol."},{"issue":"1","key":"3105_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-12-71","volume":"12","author":"L Zhenye","year":"2014","unstructured":"L. Zhenye, L. Chuzhong, W. Youtu, L. Xiaolei, C. Lei, H. Lichuan et al. The expression of TGF-\u03b21, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas. J. Transl. Med. 12(1), 1\u20138 (2014)","journal-title":"J. Transl. Med."},{"issue":"3","key":"3105_CR36","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s12020-020-02366-6","volume":"69","author":"M Ghadir","year":"2020","unstructured":"M. Ghadir, M.E. Khamseh, M. Panahi-Shamsabad, M. Ghorbani, H. Akbari, A.Z. Mehrjardi et al. Cell proliferation, apoptosis, and angiogenesis in non-functional pituitary adenoma: association with tumor invasiveness. Endocrine 69(3), 596\u2013603 (2020)","journal-title":"Endocrine"},{"issue":"5","key":"3105_CR37","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1227\/NEU.0b013e3182417e76","volume":"70","author":"X Liu","year":"2012","unstructured":"X. Liu, S. Ma, Y. Yao, G. Li, M. Feng, K. Deng et al. Differential expression of folate receptor alpha in pituitary adenomas and its relationship to tumor behavior. Neurosurgery 70(5), 1274\u20131280 (2012)","journal-title":"Neurosurgery"},{"key":"3105_CR38","unstructured":"D. Zhemin, L. Bing, W. Qing, Yifeng M., Xiaojie L. Increase in Folate Receptor Alpha Expression in Nonfunctional Pituitary Adenomas. Turkish Neurosurgery. 25(2), 298\u2013304 (2015)"},{"issue":"4","key":"3105_CR39","doi-asserted-by":"publisher","first-page":"e96178","DOI":"10.1371\/journal.pone.0096178","volume":"9","author":"C Ling","year":"2014","unstructured":"C. Ling, M. Pease, L. Shi, V. Punj, M.S. Shiroishi, D. Commins et al. A pilot genome-scale profiling of DNA methylation in sporadic pituitary macroadenomas: association with tumor invasion and histopathological subtype. PLoS One 9(4), e96178 (2014)","journal-title":"PLoS One"},{"issue":"3","key":"3105_CR40","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.18632\/aging.102751","volume":"12","author":"S Cheng","year":"2020","unstructured":"S. Cheng, C. Li, W. Xie, Y. Miao, J. Guo, J. Wang et al. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma. Aging (Albany NY) 12(3), 2408 (2020)","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"3105_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-019-02148-3","volume":"17","author":"S Cheng","year":"2019","unstructured":"S. Cheng, W. Xie, Y. Miao, J. Guo, J. Wang, C. Li et al. Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles. J. Transl. Med. 17(1), 1\u201312 (2019)","journal-title":"J. Transl. Med."},{"issue":"15","key":"3105_CR42","doi-asserted-by":"publisher","first-page":"9580","DOI":"10.1021\/acs.analchem.9b00914","volume":"91","author":"H Wang","year":"2019","unstructured":"H. Wang, K. Chen, Z. Yang, W. Li, C. Wang, G. Zhang et al. Diagnosis of Invasive Nonfunctional Pituitary Adenomas by Serum Extracellular Vesicles. Anal. Chem. 91(15), 9580\u20139589 (2019)","journal-title":"Anal. Chem."},{"issue":"1","key":"3105_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-6249-1","volume":"19","author":"R Mjelle","year":"2019","unstructured":"R. Mjelle, S.O. Dima, N. Bacalbasa, K. Chawla, A. Sorop, D. Cucu et al. Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients. BMC Cancer 19(1), 1\u201313. (2019)","journal-title":"BMC Cancer"},{"issue":"23","key":"3105_CR44","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1038\/s41388-019-0743-4","volume":"38","author":"L Zhang","year":"2019","unstructured":"L. Zhang, W. Li, L. Cao, J. Xu, Y. Qian, H. Chen et al. PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53. Oncogene 38(23), 4590\u20134604 (2019)","journal-title":"Oncogene"},{"issue":"24","key":"3105_CR45","doi-asserted-by":"publisher","first-page":"20636","DOI":"10.18632\/oncotarget.4114","volume":"6","author":"J Wang","year":"2015","unstructured":"J. Wang, N. Ding, Y. Li, H. Cheng, D. Wang, Q. Yang et al. Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells. Oncotarget 6(24), 20636 (2015)","journal-title":"Oncotarget"},{"issue":"1","key":"3105_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep39334","volume":"6","author":"JR Hwang","year":"2016","unstructured":"J.R. Hwang, Y.-J. Cho, Y. Lee, Y. Park, H.D. Han, H.J. Ahn et al. The C-terminus of IGFBP-5 suppresses tumor growth by inhibiting angiogenesis. Sci. Rep. 6(1), 1\u201312 (2016)","journal-title":"Sci. Rep."},{"issue":"2","key":"3105_CR47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1677\/ERC-10-0018","volume":"17","author":"F Galland","year":"2010","unstructured":"F. Galland, L. Lacroix, P. Saulnier, P. Dessen, G. Meduri, M. Bernier et al. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis. Endocr. Relat. Cancer 17(2), 361\u2013371 (2010)","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"3105_CR48","first-page":"4651","volume":"18","author":"B Li","year":"2019","unstructured":"B. Li, H.B. Zhu, G.D. Song, J.H. Cheng, C.Z. Li, Y.Z. Zhang et al. Regulating the CCNB1 gene can affect cell proliferation and apoptosis in pituitary adenomas and activate epithelial\u2011to\u2011mesenchymal transition. Oncol. Lett. 18(5), 4651\u20134658 (2019)","journal-title":"Oncol. Lett."},{"key":"3105_CR49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jocn.2017.05.005","volume":"43","author":"P Zhao","year":"2017","unstructured":"P. Zhao, P. Zhang, W. Hu, H. Wang, G. Yu, Z. Wang et al. Upregulation of cyclin B1 plays potential roles in the invasiveness of pituitary adenomas. J. Clin. Neurosci. 43, 267\u201373. (2017)","journal-title":"J. Clin. Neurosci."},{"key":"3105_CR50","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fendo.2021.646210","volume":"12","author":"J Gil","year":"2021","unstructured":"J. Gil, M. Jord\u00e0, B. Soldevila, M. Puig-Domingo, Epithelial\u2013Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly. Front. Endocrinol. 12, 226 (2021)","journal-title":"Front. Endocrinol."},{"key":"3105_CR51","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3389\/fcell.2020.588801","volume":"8","author":"Y Song","year":"2020","unstructured":"Y. Song, X. Ma, M. Zhang, M. Wang, G. Wang, Y. Ye et al. Ezrin Mediates Invasion and Metastasis in Tumorigenesis: A Review. Front. Cell Dev. Biol. 8, 1321 (2020)","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"3105_CR52","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41416-019-0383-z","volume":"120","author":"N Li","year":"2019","unstructured":"N. Li, J. Kong, Z. Lin, Y. Yang, T. Jin, M. Xu et al. Ezrin promotes breast cancer progression by modulating AKT signals. Br. J. Cancer 120(7), 703\u201313. (2019)","journal-title":"Br. J. Cancer"},{"issue":"3","key":"3105_CR53","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1530\/EJE-17-0702","volume":"178","author":"CM Falch","year":"2018","unstructured":"C.M. Falch, A.Y. Sundaram, K.A. \u00d8ystese, K.R. Normann, T. Lekva, I. Silamikelis et al. Gene expression profiling of fast-and slow-growing non-functioning gonadotroph pituitary adenomas. Eur. J. Endocrinol. 178(3), 295\u2013307 (2018)","journal-title":"Eur. J. Endocrinol."},{"issue":"D1","key":"3105_CR54","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"M. Kanehisa, Y. Sato, M. Kawashima, M. Furumichi, M. Tanabe, KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44(D1), D457\u2013D62. (2016)","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"3105_CR55","doi-asserted-by":"publisher","first-page":"a014365","DOI":"10.1101\/cshperspect.a014365","volume":"4","author":"AS Farrell","year":"2014","unstructured":"A.S. Farrell, R.C. Sears, MYC degradation. Cold Spring Harb. Perspect. Med. 4(3), a014365 (2014)","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"9","key":"3105_CR56","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1210\/jc.2002-020309","volume":"87","author":"C McCabe","year":"2002","unstructured":"C. McCabe, K. Boelaert, L. Tannahill, A. Heaney, A. Stratford, J. Khaira et al. Vascular endothelial growth factor, its receptor KDR\/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J. Clin. Endocrinol. Metab. 87(9), 4238\u20134244 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"3105_CR57","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1089\/gtmb.2013.0447","volume":"18","author":"Y Li","year":"2014","unstructured":"Y. Li, L.-P. Zhou, P. Ma, C.-G. Sui, F.-D. Meng, X. Tian et al. Relationship of PTTG expression with tumor invasiveness and microvessel density of pituitary adenomas: a meta-analysis. Genet. Test. Mol. Biomark. 18(4), 279\u2013285 (2014)","journal-title":"Genet. Test. Mol. Biomark."},{"issue":"8","key":"3105_CR58","doi-asserted-by":"publisher","first-page":"E1237","DOI":"10.1210\/jc.2010-3040","volume":"96","author":"W Zhou","year":"2011","unstructured":"W. Zhou, Y. Song, H. Xu, K. Zhou, W. Zhang, J. Chen et al. In nonfunctional pituitary adenomas, estrogen receptors and slug contribute to development of invasiveness. J. Clin. Endocrinol. Metab. 96(8), E1237\u2013E45. (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"3105_CR59","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/15275","volume":"5","author":"AP Heaney","year":"1999","unstructured":"A.P. Heaney, G.A. Horwitz, Z. Wang, R. Singson, S. Melmed, Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat. Med. 5(11), 1317\u20131321 (1999)","journal-title":"Nat. Med."},{"issue":"5","key":"3105_CR60","first-page":"1030","volume":"13","author":"Y Qian","year":"2020","unstructured":"Y. Qian, C. Zhang, W. Wang, D. Lu, J. Li, L. Li et al. Hypoxia promotes proliferation of pituitary adenomas by HIF-1\u03b1\/ALKBH5 signaling in vitro. Int. J. Clin. Exp. Pathol. 13(5), 1030 (2020)","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"7","key":"3105_CR61","doi-asserted-by":"publisher","first-page":"8923","DOI":"10.1007\/s13277-015-4767-2","volume":"37","author":"S-Y Yu","year":"2016","unstructured":"S.-Y. Yu, L.-C. Hong, J. Feng, Y.-T. Wu, Y.-Z. Zhang, Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas. Tumor Biol. 37(7), 8923\u20138930 (2016)","journal-title":"Tumor Biol."},{"issue":"4","key":"3105_CR62","doi-asserted-by":"publisher","first-page":"1-","DOI":"10.3892\/ol.2021.12525","volume":"21","author":"J Guo","year":"2021","unstructured":"J. Guo, Q. Fang, Y. Liu, W. Xie, Y. Zhang, C. Li, Identifying critical protein\u2011coding genes and long non\u2011coding RNAs in non\u2011functioning pituitary adenoma recurrence. Oncol. Lett. 21(4), 1- (2021)","journal-title":"Oncol. Lett."},{"issue":"17","key":"3105_CR63","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.3390\/ijms22179207","volume":"22","author":"J Sinsky","year":"2021","unstructured":"J. Sinsky, K. Pichlerova, J. Hanes, Tau Protein Interaction Partners and Their Roles in Alzheimer\u2019s Disease and Other Tauopathies. Int. J. Mol. Sci. 22(17), 9207 (2021)","journal-title":"Int. J. Mol. Sci."},{"key":"3105_CR64","doi-asserted-by":"crossref","unstructured":"Z. Zimu, Z. Jia, F. Xian, M. Rui, R. Yuting, W. Yuan, et al. Decreased Expression of PACSIN1 in Brain Glioma Samples Predicts Poor Prognosis. Front. Mol. Biosci. 772, 1\u201311 (2021)","DOI":"10.3389\/fmolb.2021.696072"},{"issue":"3","key":"3105_CR65","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11102-020-01109-0","volume":"24","author":"Z Wei","year":"2021","unstructured":"Z. Wei, C. Zhou, M. Li, R. Huang, H. Deng, S. Shen et al. Integrated multi-omics profiling of nonfunctioning pituitary adenomas. Pituitary 24(3), 312\u201325 (2021)","journal-title":"Pituitary"},{"key":"3105_CR66","doi-asserted-by":"crossref","unstructured":"J. Boresowicz, P. Kober, N. Rusetska, M. Maksymowicz, A. Paziewska, M. D\u0105browska, et al. The Search of miRNA Related to Invasive Growth of Nonfunctioning Gonadotropic Pituitary Tumors. Int. J. Endocrinol. 2020, 1\u20138 (2020)","DOI":"10.1155\/2020\/3730657"},{"issue":"1","key":"3105_CR67","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neulet.2007.02.070","volume":"417","author":"L Chen","year":"2007","unstructured":"L. Chen, Y. Liu, Y. Hou, Y. Kato, H. Sano, T. Kanno, Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas. Neurosci. Lett. 417(1), 30\u201335 (2007)","journal-title":"Neurosci. Lett."},{"issue":"1","key":"3105_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0798-z","volume":"7","author":"SJ Park","year":"2019","unstructured":"S.J. Park, H. Kim, S.H. Kim, E.-H. Joe, I. Jou, Epigenetic downregulation of STAT6 increases HIF-1\u03b1 expression via mTOR\/S6K\/S6, leading to enhanced hypoxic viability of glioma cells. Acta Neuropathologica Commun. 7(1), 1\u201319 (2019)","journal-title":"Acta Neuropathologica Commun."},{"issue":"1","key":"3105_CR69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3892\/ol.2016.4560","volume":"12","author":"Y Wu","year":"2016","unstructured":"Y. Wu, J. Bai, L. Hong, C. Liu, S. Yu, G. Yu et al. Low expression of secreted frizzled-related protein 2 and nuclear accumulation of \u03b2-catenin in aggressive nonfunctioning pituitary adenoma. Oncol. Lett. 12(1), 199\u2013206 (2016)","journal-title":"Oncol. Lett."},{"issue":"3","key":"3105_CR70","doi-asserted-by":"publisher","first-page":"168","DOI":"10.24920\/003585","volume":"34","author":"S Yu","year":"2019","unstructured":"S. Yu, X. Wang, K. Cao, X. Bao, J. Yu, Identification of CDK6 and RHOU in serum exosome as biomarkers for the invasiveness of non-functioning pituitary adenoma. Chin. Med. Sci. J. 34(3), 168\u2013176 (2019)","journal-title":"Chin. Med. Sci. J."},{"key":"3105_CR71","doi-asserted-by":"crossref","unstructured":"V. Cescato, E. Pinto, N. de Castro Musolino, S. Siqueira, M. Teixeira, editors. BCL2, BAX and CASP3 Apoptosis Related Genes Expression in Non-Functioning Pituitary Adenoma and Their Role as Potential Markers of Tumor Behavior. Endocr. Rev. 240\u2013241 (2010)","DOI":"10.1210\/endo-meetings.2010.PART1.P5.P1-240"},{"issue":"3","key":"3105_CR72","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"M. Malumbres, M. Barbacid, Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9(3), 153\u201366. (2009)","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"3105_CR73","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.4161\/cc.25515","volume":"12","author":"T Komori","year":"2013","unstructured":"T. Komori, Regulation of Rb family proteins by Cdk6\/Ccnd1 in growth plates. Cell Cycle 12(14), 2161\u20132162 (2013)","journal-title":"Cell Cycle"},{"key":"3105_CR74","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fendo.2017.00055","volume":"8","author":"LJT de Ara\u00fajo","year":"2017","unstructured":"L.J.T. de Ara\u00fajo, A.M. Lerario, M. de Castro, C.S. Martins, M.D. Bronstein, M.C. Machado et al. Transcriptome analysis showed a differential signature between invasive and non-invasive corticotrophinomas. Front. Endocrinol. 8, 55 (2017)","journal-title":"Front. Endocrinol."},{"issue":"5","key":"3105_CR75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrendo.2011.40","volume":"7","author":"S Melmed","year":"2011","unstructured":"S. Melmed, Pathogenesis of pituitary tumors. Nat. Rev. Endocrinol. 7(5), 257\u2013266 (2011)","journal-title":"Nat. Rev. Endocrinol."},{"issue":"12","key":"3105_CR76","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/jcm5120109","volume":"5","author":"N Sun","year":"2016","unstructured":"N. Sun, A. Taguchi, S. Hanash, Switching roles of TGF-\u03b2 in cancer development: implications for therapeutic target and biomarker studies. J. Clin. Med. 5(12), 109 (2016)","journal-title":"J. Clin. Med."},{"key":"3105_CR77","doi-asserted-by":"crossref","unstructured":"S. Espiard, M.J. Knape, K. Bathon, G. Assi\u00e9, M. Rizk-Rabin, S. Faillot, et al. Activating PRKACB somatic mutation in cortisol-producing adenomas. JCI insight. 3(8), 1\u201311 (2018)","DOI":"10.1172\/jci.insight.98296"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03105-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03105-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03105-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T06:42:36Z","timestamp":1666334556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03105-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":77,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["3105"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03105-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"31 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}